Finance

Lists
Why is BRKR down 3,08%?
Dive Deeper
BRKR:NASDAQ
Bruker Corp
54,80 US$
-3,08%
(-1,74) 1D
54,80 US$
0,00% (0,00)
After hours
Closed: 16 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRKR...
Open
56,45 US$
High
57,18 US$
Low
54,26 US$
Mkt. cap
8,35 მლრდ.
Avg. vol.
2,29 მლნ.
Volume
1,67 მლნ.
Dividend
0,36%
Quarterly dividend
0,05 US$
Ex-dividend date
21 სექ. 2026
52-wk high
66,98 US$
52-wk low
32,38 US$
EPS
-0,70 US$
Beta
1,22
Shares outstanding
152,36 მლნ.
No. of employees
11 ათ.
Open
56,45 US$
High
57,18 US$
Low
54,26 US$
Mkt. cap
8,35 მლრდ.
Avg. vol.
2,29 მლნ.
Volume
1,67 მლნ.
Dividend
0,36%
Quarterly dividend
0,05 US$
Ex-dividend date
21 სექ. 2026
52-wk high
66,98 US$
52-wk low
32,38 US$
EPS
-0,70 US$
Beta
1,22
Shares outstanding
152,36 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
Profile
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize. Wikipedia
About Bruker Corp
CEOფრენკ ლაუკინ
Employees11,1 ათ.
Founded1960
HeadquartersBillerica, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth care
Websitebruker.com
Analyst ratings
Based on 10 analysts giving stock ratings to BRKR in the past 3 months
Buy
Buy
5
Hold
4
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BRKR in the last 3 months.
Highest
Current 54,80 US$
80,00 US$ (+45,99%)
Average
61,33 US$ (+11,92%)
Lowest
50,00 US$ (-8,76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Casey Woodring
J.P. Morgan
Hold
Downgraded
60,00 US$
+9,5%
10/14/2026
Daniel Brennan
TD Cowen
Hold
Maintained
62,00 US$
+13,1%
10/13/2026
Luke Sergott
Barclays
Buy
Maintained
70,00 US$
+27,7%
10/07/2026
Unknown Analyst
Goldman Sachs
Sell
Maintained
50,00 US$
-8,8%
10/05/2026
Evie Koslosky
Goldman Sachs
Sell
Maintained
50,00 US$
-8,8%
10/05/2026
Subbu Nambi
Guggenheim
Buy
Maintained
72,00 US$
+31,4%
10/01/2026
Puneet Souda
Leerink Partners
Buy
Maintained
80,00 US$
+46%
09/29/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
08/05/2026
Evan Stampler
Wells Fargo
Buy
Maintained
55,00 US$
+0,4%
08/05/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
55,00 US$
+0,4%
08/05/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
50,00 US$
-8,8%
08/05/2026
Patrick B Donnelly
Citi
Hold
Maintained
53,00 US$
-3,3%
08/05/2026
Kyle Boucher
TD Cowen
Hold
Maintained
60,00 US$
+9,5%
08/04/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Dan Leonard
RBC Capital
Hold
Reiterated
45,00 US$
-17,9%
05/07/2026
Tycho Peterson
Jefferies
Buy
Maintained
50,00 US$
-8,8%
02/12/2026
Last report
4 აგვ. 2026
Fiscal period
Q2 2026
0,49 US$ / 0,38 US$
+27,49%beat
Revenue / Est. (USD)
838,50 მლნ. / 853,57 მლნ.
-1,77%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
860,50 მლნ.
977,20 მლნ.
823,40 მლნ.
838,50 მლნ.
Cost of goods sold
446,30 მლნ.
510,40 მლნ.
428,20 მლნ.
421,40 მლნ.
Cost of revenue
446,30 მლნ.
510,40 მლნ.
428,20 მლნ.
421,40 მლნ.
Research and development expenses
98,30 მლნ.
99,60 მლნ.
101,30 მლნ.
94,30 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
242,50 მლნ.
244,20 მლნ.
242,10 მლნ.
238,90 მლნ.
Operating expense
302,70 მლნ.
402,50 მლნ.
344,30 მლნ.
334,30 მლნ.
Total operating expenses
749,00 მლნ.
912,90 მლნ.
772,50 მლნ.
755,70 მლნ.
Operating income
111,50 მლნ.
64,30 მლნ.
50,90 მლნ.
82,80 მლნ.
Other non operating income
9,30 მლნ.
-5,70 მლნ.
3,00 მლნ.
4,00 მლნ.
EBT including unusual items
-72,60 მლნ.
67,00 მლნ.
18,20 მლნ.
-36,70 მლნ.
EBT excluding unusual items
106,60 მლნ.
54,20 მლნ.
47,30 მლნ.
87,90 მლნ.
Income tax expense
-14,10 მლნ.
37,80 მლნ.
2,50 მლნ.
14,20 მლნ.
Effective tax rate
19,42%
56,42%
13,74%
-38,69%
Other operating expenses
-38,10 მლნ.
58,70 მლნ.
800,00 ათ.
1,10 მლნ.
Net income
-59,60 მლნ.
26,00 მლნ.
14,40 მლნ.
-52,00 მლნ.
Net profit margin
-6,93%
2,66%
1,75%
-6,20%
Earnings per share
0,45
0,59
0,31
0,49
Interest and investment income
4,40 მლნ.
4,60 მლნ.
4,90 მლნ.
11,30 მლნ.
Interest expense
-20,30 მლნ.
-11,20 მლნ.
-12,20 მლნ.
-17,80 მლნ.
Net interest expenses
-15,90 მლნ.
-6,60 მლნ.
-7,30 მლნ.
-6,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
167,20 მლნ.
122,40 მლნ.
109,20 მლნ.
140,80 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები